NewsRoom Articles - Page 193 of 591

ThursdayFeb 17, 2022 4:20 pm

420 with CNW — Congress Briefed on Federal Courts’ Varying Interpretations of Marijuana Clause

Lawmakers in Congress have been briefed on a report that shows the varying interpretation of a medical marijuana protection rider. Since 2014, Congress has included provisions in appropriations acts that exclude the U.S. Department of Justice (“DOJ”) funding from being used to prevent states and jurisdictions from enforcing medical marijuana laws. The provision, which is renewed during every financial year, lists a total of 52 jurisdictions and prevents the Justice Department from taking legal actions against these territories. A new report, released on Feb. 4, 2022, from the Congressional Research Service (“CRS”), reveals how federal courts have varyingly interpreted the…

ThursdayFeb 17, 2022 4:20 am

420 with CNW — Factors Hindering Research on Medical Marijuana

The number of states legalizing cannabis for medical and recreational use is growing in the United States. This comes as cannabis product marketing increases, more companies enter the flourishing market and the call for the federal prohibition on cannabis to be removed grows. However, while more research on the therapeutic use of the plant is conducted, many universities and states are finding it hard to carry out as much research on marijuana’s clinical applicability as they want to because of the various hurdles that hinder progression of clinical studies. For instance, the DEA has strict licensing regulations for providers to…

WednesdayFeb 16, 2022 4:20 pm

420 with CNW — Justice Dept. Considering Measures for Safe Drug Consumption Sites

The Department of Justice (“DOJ”) is evaluating the authorization of harm reduction centers for people to use currently illicit drugs in a supervised environment and receive treatment resources. New York City became the first state to launch safe drug consumption sites in November 2021. Then Mayor Bill de Blasio (D-NY) said that the so-called Overdose Prevention Centers are an effective option in addressing the opioid crisis. According to the AP, the sites have prevented 125 overdoses. Advocates are eager to hear the federal government’s response in a lawsuit over a proposal that could see the establishment of similar centers in…

WednesdayFeb 16, 2022 11:25 am

Following Successful Sildenafil Animal Study, Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Plans for More Studies in 2022

Lexaria’s animal study could be the first step to developing faster and better acting sildenafil oral formulations The most prominent study for Lexaria in 2022 is HYPER-H21-4, investigating patented DehydraTECH(TM)-CBD for hypertension and heart disease Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced positive findings in an animal study that evaluated DehydraTECH(TM) processing of the phosphodiesterase inhibitor (PDE5 inhibitor) sildenafil as potential use for erectile dysfunction management. A clear trend emerged during the course of the study – a faster and higher overall delivery of sildenafil into the bloodstream (https://cnw.fm/SOjPD). During the animal study, it…

WednesdayFeb 16, 2022 4:20 am

420 with CNW — New Congressional Bill Plans to Raise THC Limit for Hemp

Earlier this week, Rep. Chellie Pingree filed a measure which will make some crucial reforms to the hemp industry, including increasing the legal threshold for THC in hemp products to 1% from 0.3% on a dry weight basis. The measure, dubbed the Hemp Advancement Act, would also address an issue associated with levels of THC for in-process hemp. Many businesses had raised concerns about the THC limit stipulated under the existing federal statute previously, as the process of extracting hemp could temporarily increase the content of THC in a plant in a way that made them liable for enforcement action.…

TuesdayFeb 15, 2022 4:20 pm

420 with CNW — Veteran Cannabis Lobbyist Unveils New Political Group

Last week a veteran marijuana lobbyist launched a new political action commission (“PAC”) that will push for reforms designed to end federal marijuana prohibition. The Better Organizing to Win Legalization (“BOWL”) PAC will also work with other organizations to support politicians and elected officials who are advancing reforms for marijuana legalization. Justin Strekal launched BOWL PAC with the aim of encouraging organizations and advocacy groups that are not actively involved to be more proactive in backing efforts for legalization. Strekal said he intends to reach out to organizations and groups that say they are supporting cannabis legalization but “are not…

TuesdayFeb 15, 2022 4:20 am

420 with CNW — Data from UK Registry Reveals Medical Marijuana Improves Patients’ Quality of Life

A study conducted by the UK Medical Cannabis Registry reveals the association between prescribed medical marijuana and an improvement in the quality of life of a patient. The UK Medical Cannabis Registry is a first-of-its-kind database known to contain details of the largest group of patients that have been prescribed medical marijuana. The registry was set up by Sapphire Medical, a medical cannabis clinic providing patients with an expert assessment of their health conditions and considerations for using medicinal cannabis for treatment. The data in the registry is anonymous and is available upon request to the medical community. The study…

MondayFeb 14, 2022 4:20 pm

420 with CNW — Report Finds Marijuana Has Contributed $43+ Billion to Canada’s GDP

A recent report by Deloitte Canada states that marijuana has contributed more than $43 billion to the country’s gross domestic product (“GDP”). Since recreational marijuana was legalized in 2018, it has also contributed more than $13 billion to Ontario’s GDP. The report, which was compiled with help from the Ontario Cannabis Store, stated that for every $1 in capital expenditures or revenue, the marijuana industry added roughly $1.02 and $1.09 to Ontario’s and Canada’s gross domestic product from legal purchases. The Ontario Cannabis Store is a provincial distributor of cannabis. The report also provides insight into how the marijuana industry…

MondayFeb 14, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Seeks EUA to Test Cannabis Product Against COVID Virus, Building on Early Study Results as it Names New Chief Strategy Officer

Recent research efforts have targeted the potential of cannabis compounds to combat COVID-19 infection as the worldwide pandemic presses forward into its third year Perhaps most notable among the early-stage research efforts is a study by Oregon State University that found high doses of two specific cannabinoids bound to spike proteins such as COVID’S SARS-CoV-2 and inhibited their potential for infection Cannabis cultivator and brand builder Flora Growth Corp. has filed a provisional patent application for a cannabinoid-based formula that it is simultaneously seeking approval from Colombia’s food and drug regulatory authority for a study and potential clinical trial in…

MondayFeb 14, 2022 4:20 am

420 with CNW — Cosmetics Sector Now Eying CBG as an Ingredient

We’ve seen the CBD market grow significantly these last few months in different parts of the globe, with projections showing that by 2028, the market could be valued at $13 billion. CBD has various benefits, which include relieving anxiety and providing pain relief along with anti-acne and anti-seizure properties. Some studies have also found that CBD may help prevent growth of cancer cells. However, more research is needed to support these claims. CBD isn’t the only compound various markets are interested in either, as the wellness and cosmetic markets have begun to take an interest in CBG (cannabigerol), which is…